Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase

Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase

Human esophageal cancer has a global impact on human health due to its high incidence and mortality. Therefore, there is an urgent need to develop new drugs to treat or prevent the prominent pathological subtype of esophageal cancer, esophageal squamous cell carcinoma (ESCC). Based upon the screenin...

Full description

Bibliographic Details
Main Authors: Ning Yang, Xuebo Lu, Yanan Jiang, Lili Zhao, Donghao Wang, Yaxing Wei, Yin Yu, Myoung Ok Kim, Kyle Vaughn Laster, Xin Li, Baoyin Yuan, Zigang Dong, Kangdong Liu
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2022-09-01
Series:eLife
Subjects:
ESCC
mass spectrometry
signaling pathway
Online Access:https://elifesciences.org/articles/73953

Internet

https://elifesciences.org/articles/73953

Similar Items